Environmental tobacco smoke and children's health

Sang-Hyun Hwang1, Jong Hee Hwang, Jin Soo Moon

  • 1Department of Laboratory Medicine, Center for Diagnostic Oncology, National Cancer Center, Goyang, Korea.

Insights

Environmental tobacco smoke (ETS) poses significant health risks to children, impacting fetal development and pediatric health. Hair analysis offers a reliable method for assessing long-term exposure to nicotine and cotinine, crucial for protecting children from secondhand smoke.

Area of Science:

  • Environmental Health
  • Pediatric Health
  • Toxicology

Background:

  • Passive exposure to environmental tobacco smoke (ETS) is a major cause of illness and death in children.
  • Children are uniquely vulnerable to ETS, which is linked to adverse outcomes like preterm birth, developmental issues, and respiratory illnesses.
  • Accurate measurement of tobacco exposure is vital for risk assessment.

Purpose of the Study:

  • To highlight the risks of ETS exposure in children.
  • To discuss the utility of nicotine and cotinine as biomarkers for tobacco exposure.
  • To introduce hair analysis as a noninvasive method for assessing long-term ETS exposure.

Main Methods:

  • Review of existing literature on ETS effects on pediatric health.
  • Discussion of nicotine and cotinine as biomarkers.
  • Introduction of hair analysis for detecting nicotine/cotinine accumulation.

Main Results:

  • ETS exposure is associated with numerous adverse pediatric health outcomes.
  • Nicotine and cotinine levels in biological samples (blood, saliva, urine) indicate exposure.
  • Hair analysis provides a convenient, noninvasive measure of cumulative, long-term nicotine exposure.

Conclusions:

  • Despite smoking bans, children remain significantly exposed to ETS in various public and private settings.
  • Hair analysis is a valuable tool for assessing cumulative exposure to tobacco smoke.
  • Consolidated strategies and public policies are needed to protect children from ETS.

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.